Phase I dose-escalation study of NBTXR3 activated by intensity-modulated radiation therapy in elderly patients with locally advanced squamous cell carcinoma of the oral cavity or oropharynx

Authors: Hoffmann, Caroline, Calugaru, Valentin, Borcoman, Edith, Moreno, Victor, Calvo, Emiliano, Liem, Xavier, Salas, Sébastien, Doger, Bernard, Jouffroy, Thomas, Mirabel, Xavier, Rodriguez, Jose, Chilles, Anne, Bernois, Katell, Dimitriu, Mikaela, Fakhry, Nicolas, Hee Kam, Stéphanie Wong, Le Tourneau, Christophe

Source: In European Journal of Cancer March 2021 146:135-144

Phase I study of functionalized hafnium oxide nanoparticles (NBTXR3) activated by radiotherapy in cisplatin-ineligible locally advanced HNSCC patients.

Authors: Le Tourneau, Christophe, Calugaru, Valentin, Takacsi-Nagy, Zoltan, Liem, Xavier, Papai, Zsuzsanna, Fijuth, Jacek, Moreno, Victor, Giralt, Jordi, Salas, Sébastien, Poissonnet, Gilles, Calvo, Emiliano, Doger, Bernard, Choussy, Olivier, Mirabel, Xavier, Krhili, Samar, Bernois, Katell, Fakhry, Nicolas, Wong-Hee-Kam, Stéphanie, Borcoman, Edith, Hoffmann, Caroline

Source: Journal of clinical oncology. 39(15 suppl):6051-6051

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100174762360.0x000001&indx=1&recIds=ETOCvdc_100174762360.0x000001

Radiation enhancing hafnium oxide nanoparticles (NBTXR3) for the treatment of cisplatin-ineligible locally advanced HNSCC patients: a phase I dose expansion study

Authors: Tourneau, Christophe Le, Calugaru, Valentin, Moreno, Victor, Calvo, Emiliano, Liem, Xavier, Salas, Sébastien, Doger, Bernard, Jouffroy, Thomas, Mirabel, Xavier, Rodriguez, Jose, Chilles, Anne, Bernois, Katell, Fakhry, Nicolas, Kam, Stéphanie Wong Hee, Hoffmann, Caroline

Source: In Oral Oncology July 2021 118 Supplement:11-11

This result is not displayed to guests.
Login for full access.

This result is not displayed to guests.
Login for full access.

This result is not displayed to guests.
Login for full access.